Tesetaxel
Tesetaxel (DJ-927) is an orally active and brain-penetrant taxane tubulin inhibitor. Tesetaxel inhibits tubulin depolymerization with an IC50 of 0.44 μM. Tesetaxel inhibits cancer cells proliferation and shows potent antitumor activity against P-glycoprotein-positive cancer cells. Tesetaxel can be used for the research of cancer, such as solid tumors, liver metastasis, and advanced breast cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 333754-36-2
- Fòrmula: C46H60FN3O13
- Peso molecular:881.98
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PC-6 | GI50 |
0.38 ng/mL
Compound: 165
|
Growth inhibition of human PC-6 cells
Growth inhibition of human PC-6 cells
|
[PMID: 34213340] |
Tesetaxel inhibits porcine brain tubulin depolymerization with an IC50 of 0.44 μM and does not inhibit tubulin polymerization (IC50 >2.0 μM)[1].
Tesetaxel shows mean GI50 value of 0.550 ng/mL against the 23 different human tumor cells[1].
Tesetaxel exhibits greater cytotoxicity than Paclitaxel (HY-B0015) and Docetaxel (HY-B0011) against P-gp-overexpressing resistant PC-6 and HCT116 cell lines[1].
Tesetaxel (10 days) inhibits colony formation of M5076 cells with an IC50 of 5.5 ng/mL, and its activity is unaffected by the P-gp modulator Verapamil (HY-14275)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:murine ovarian histiocytoma M5076 cells (moderate P-gp expression)
-
Concentration:5.5 ng/mL
-
Incubation Time:10 days
-
Result:Inhibited colony formation with an IC50 of 5.5 ng/mL, which was 10- to 100-fold lower than Paclitaxel and Docetaxel.
Showed unaltered activity with simultaneous addition of Verapamil.
Tesetaxel (12 mg/kg; p.o.; single dose) achieves greater than 90% tumor growth inhibition against P-glycoprotein-positive human breast cancer DU4475 xenografts in male BALB/c-nu/nu mice[1].
Tesetaxel (9.8 mg/kg; p.o. or i.v.; once every 8 days; 2 doses) prolongs the life o in male C57BL/6 mice with P-glycoprotein-positive M5076 liver metastatic tumors[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c-nu/nu with DLD-1 xenografts (male)[1]
-
Dosage:9.80 mg/kg
-
Administration:p.o.; once every 8 days; 2 doses
-
Result:Achieved an inhibition rate (IR) greater than 90% against DLD-1 xenografts.
-
Animal Model:C57BL/6 with DLD-1 M5076 xenografts (male)[1]
-
Dosage:9.8 mg/kg
-
Administration:p.o. or i.v.; once every 8 days; 2 doses
-
Result:Produced an increase in life span (ILS) of 135% and 155%.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 333754-36-2
-
Peso molecular 881.98
-
Fòrmula C46H60FN3O13
-
SMILES
CC(O[C@]12[C@]3([H])[C@]([C@@]4([H])[C@@](O[C@H](O4)CN(C)C)([H])C5=C(C)[C@@H](OC([C@H](O)[C@H](C6=C(C=CC=N6)F)NC(OC(C)(C)C)=O)=O)C[C@@](O)([C@H]3OC(C7=CC=CC=C7)=O)C5(C)C)(CC[C@@]1([H])OC2)C)=O
-
Synonyms
DJ-927
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Tesetaxel Related Classifications
HY-16491 Related Classifications
Powered by Bioz